Serena Marchi , Valentina Salvestroni , Bianca Maria Bocci , Giovanni Guarducci , Giovanna Milano , Anna Carmina De Francesco , Emanuele Montomoli , Giovanni Bova , Andrea Camarri , Ilaria Manini
{"title":"后covid -19时代的SARS-CoV-2、流感、HRSV和其他呼吸道病原体:2023/2024季节意大利的流行病传播","authors":"Serena Marchi , Valentina Salvestroni , Bianca Maria Bocci , Giovanni Guarducci , Giovanna Milano , Anna Carmina De Francesco , Emanuele Montomoli , Giovanni Bova , Andrea Camarri , Ilaria Manini","doi":"10.1016/j.jiph.2025.102905","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed at describing the epidemiological aspects of respiratory pathogens involved in cases of severe acute respiratory infections (SARI) in Siena (Tuscany, Italy) during the 2023/2024 season.</div></div><div><h3>Methods</h3><div>Oropharyngeal swabs were collected from enrolled patients in the University Hospital Trust of Siena. Swabs were tested by qRT-PCR for the detection of SARS-CoV-2 and other 21 respiratory pathogens, including influenza and human respiratory syncytial virus (HRSV). Swabs positive for SARS-CoV-2 and/or influenza were further analyzed by Next-Generation sequencing (NGS).</div></div><div><h3>Results</h3><div>From January to June 2024, 138 patients diagnosed with SARI were enrolled, with an average age of 76.7 years and a frequent presence of comorbidities. Among the patients, 40 % tested positive for SARS-CoV-2, followed by 20 % positivity for influenza and 13 % positivity for HRSV. For SARS-CoV-2, variants belonging to the JN.1, EG.5 and BA.5 lineages were found. The influenza A(H1N1)pdm09 strains were found to belong to the 6B.1a.5a.2a clade, while for influenza A(H3N2), the strains belonged to two different clades (3 C.2a1b.2a.1a and 3 C.2a1b. 2a.2a.3a.1).</div></div><div><h3>Conclusions</h3><div>This study contributes to the understanding of the spread of respiratory viruses and the genetic characteristics of SARS-CoV-2 and influenza in patients with SARI, underlining the importance of continuous surveillance.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 11","pages":"Article 102905"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season\",\"authors\":\"Serena Marchi , Valentina Salvestroni , Bianca Maria Bocci , Giovanni Guarducci , Giovanna Milano , Anna Carmina De Francesco , Emanuele Montomoli , Giovanni Bova , Andrea Camarri , Ilaria Manini\",\"doi\":\"10.1016/j.jiph.2025.102905\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>This study aimed at describing the epidemiological aspects of respiratory pathogens involved in cases of severe acute respiratory infections (SARI) in Siena (Tuscany, Italy) during the 2023/2024 season.</div></div><div><h3>Methods</h3><div>Oropharyngeal swabs were collected from enrolled patients in the University Hospital Trust of Siena. Swabs were tested by qRT-PCR for the detection of SARS-CoV-2 and other 21 respiratory pathogens, including influenza and human respiratory syncytial virus (HRSV). Swabs positive for SARS-CoV-2 and/or influenza were further analyzed by Next-Generation sequencing (NGS).</div></div><div><h3>Results</h3><div>From January to June 2024, 138 patients diagnosed with SARI were enrolled, with an average age of 76.7 years and a frequent presence of comorbidities. Among the patients, 40 % tested positive for SARS-CoV-2, followed by 20 % positivity for influenza and 13 % positivity for HRSV. For SARS-CoV-2, variants belonging to the JN.1, EG.5 and BA.5 lineages were found. The influenza A(H1N1)pdm09 strains were found to belong to the 6B.1a.5a.2a clade, while for influenza A(H3N2), the strains belonged to two different clades (3 C.2a1b.2a.1a and 3 C.2a1b. 2a.2a.3a.1).</div></div><div><h3>Conclusions</h3><div>This study contributes to the understanding of the spread of respiratory viruses and the genetic characteristics of SARS-CoV-2 and influenza in patients with SARI, underlining the importance of continuous surveillance.</div></div>\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"18 11\",\"pages\":\"Article 102905\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034125002540\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002540","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season
Objectives
This study aimed at describing the epidemiological aspects of respiratory pathogens involved in cases of severe acute respiratory infections (SARI) in Siena (Tuscany, Italy) during the 2023/2024 season.
Methods
Oropharyngeal swabs were collected from enrolled patients in the University Hospital Trust of Siena. Swabs were tested by qRT-PCR for the detection of SARS-CoV-2 and other 21 respiratory pathogens, including influenza and human respiratory syncytial virus (HRSV). Swabs positive for SARS-CoV-2 and/or influenza were further analyzed by Next-Generation sequencing (NGS).
Results
From January to June 2024, 138 patients diagnosed with SARI were enrolled, with an average age of 76.7 years and a frequent presence of comorbidities. Among the patients, 40 % tested positive for SARS-CoV-2, followed by 20 % positivity for influenza and 13 % positivity for HRSV. For SARS-CoV-2, variants belonging to the JN.1, EG.5 and BA.5 lineages were found. The influenza A(H1N1)pdm09 strains were found to belong to the 6B.1a.5a.2a clade, while for influenza A(H3N2), the strains belonged to two different clades (3 C.2a1b.2a.1a and 3 C.2a1b. 2a.2a.3a.1).
Conclusions
This study contributes to the understanding of the spread of respiratory viruses and the genetic characteristics of SARS-CoV-2 and influenza in patients with SARI, underlining the importance of continuous surveillance.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.